Поиск
Закладки
Озвучить текст Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.
Глаукома первичная закрытоугольная

Список литературы

  1. Terminology and guidelines for glaucoma. European glaucoma society, 4th ed. 2014 – 192 p.
  2. Национальное руководство по глаукоме. Руководство для практикующих врачей, изд. 4-е. М., ГЭОТАР-Медиа. – 2019 – 384 с.
  3. World Glaucoma Association Consensus Statement: Angle Closure and Angle Closure Glaucoma / Weinreb RN, Friedman DS, eds. // The Netherlands: Kluger. – 2006 – 113 p.
  4. Primary Angle Closure / American Academy of Ophthalmology Preferred Practice Pattern® Guidelines, San Francisco. 2015 – 40 p.
  5. Shaarawy T.M., Sherwood M.B., Hitchimgs R.A., Crowston J.G. Glaucoma: medical diagnosis and therapy, 2-nd (Vol.1). London: Elsevir, 2015:1201
  6. Glaucoma in Mongolia. A population-based survey in Hovsgol province, northern Mongolia / Foster PJ, Baasanhu J, Alsbirk PH, et al. // Arch Ophthalmol. – 1996 – Vol. 114. – P. 1235-41.
  7. The prevalence of glaucoma / Bengtsson B. // Br J Ophthalmol. – 1981 – Vol. 65. – P. 46-9.
  8. Risk of acute angle-closure glaucoma after diagnostic mydriasis in nonselected subjects: the Rotterdam Study / Wolfs RC, Grobbee DE, Hofman A, de Jong PT. // Invest Ophthalmol Vis Sci. – 1997 – Vol. 38. – P. 2683-7.
  9. Issues in the Epidemiology and Population-Based Screening of Primary Angle-Closure Glaucoma / Congdon N., Wang F., Tielsch J.M. // Surv Ophthalmol. – 1992 – Vol. 36. – P. 411-423.
  10. Epidemiology of acute primary angle-closure glaucoma in the Hong Kong Chinese population: prospective study / Lai JS, Liu DT, Tham CC, et al. // Hong Kong Med J. – 2001 – Vol. 7. – P. 118-23.
  11. Family studies in glaucoma / Perkins ES. // Br J Ophthalmol. – 1974 – Vol. 58. – P. 529-35.
  12. Survey of the first-degree relatives of glaucoma patients / Leighton DA. // Trans Ophthalmol Soc UK. – 1976 – Vol. 96. – P. 28-32.  
  13. Злокачественная глаукома: диагностика, клиника, лечение / Ефимова М.Н. // Глаукома. 2002 - №1 – С. 53-60.
  14. Possible mechanisms of primary angle-closure and malignant glaucoma. / Quigley HA, Friedman DS, Congdon NG. // J Glaucoma 2003 – Vol. 12. – №2.  – P. 167-180.
  15. Nanophthalmic sclera; morphologic and tissue culture studiem. / Yue BYJT, Duvall J, Goldberg MF, Puck A, Tso MO, Sugar // J. Ophtalmology. – 1986 –  Vol 93. – P. 534-541.
  16. Global data on visual impairment in the year 2002. / Resnikoff S., Pascolini D., Etyaale D., Kocur I., Pararajasegaram P., Pjkharel G.P. et al. // WHO Bull. – 2004. – Vol. 82. – P. 844-855.
  17. The number of persons with glaucoma worldwide in 2010 and 2020. / Quigley HA, Broman AT. // Br J Ophthalmol. 2006. – Vol. 90. – P. 262-267.
  18. Angle closure glaucoma in an urban population in southern India. The Andhra Pradesh eye disease study. / Dandona L., Dandona R., Mandal P., Srinivas M., John R.K., McCarty C.A., et al. // Ophthalmology. – 2000 – Vol. 107. – P. 1710-1716.
  19. Prevalence of primary glaucoma in an urban south Indian population. / Jacob A., Thomas R., Koshi S.P., Braganza A., Muliyil J. // Ind J Ophthalmol. – 1998. – Vol. 46. – P. 81-86.
  20. Glaucoma in a rural population of southern India: the Aravind comprehensive eye survey. / Ramakrishnan R., Nirmalan P.K., Krishnadas R., Thulasiraj R.D., Tielsch J.M., Katz J., et al. // Ophthalmology. – 2003 – Vol. 110. – P. 1484-1490.
  21. Prevalence of angle-closure disease in a rural southern Indian population. / Vijaya L., George R., Arvind H., Baskaran M., Paul P.G., Ramesh S.V., et al. // Arch Ophthalmol. – 2006 – Vol. 124. – P. 403-409.
  22. Epidemiology of glaucoma in Japan – A nationwide glaucoma survey. / Shiose Y., Kitazawa Y., Tsukuhara S., Akamatsu T., Mizokami K., Futa R., et al. // Jpn J Ophthalmol. – 1991. – Vol. 35. – P. 133-135.
  23. Glaucoma in Mongolia – A poplation-based survey in Hovsgol Province, Northern Mongolia. / Foster P.J., Baasanhu J., Alsbrik P.H., Munkhbayar D., Uranchimeg D., Jonson G.J. // Arc Ophthalmol. – 1996 – Vol. 114. – P. 1235-1241.
  24. The prevalence of glaucoma in Chinese residents of Singapure. A cross-sectional population survey in Tanjong Pagar district. / Foster P.J., Oen F.T., Machin D.S., Ng T.P., Devereux J.G., Jonson G.J., et al. //  Arc Ophthalmol. – 2000 – Vol. 118. – P. 1105-1111.
  25. The Tajimi Study report 2: prevalence of primary angle closure and secondary glaucoma in a Japanese population. / Yamamoto T., Iwase A., Araie M., Suzuki Y., Abe H., Shirato S., et al. // Ophthalmology. – 2001 – Vol. 112. – P. 1661-1669.
  26. Glaucoma in China: how big is the problem? / Foster P.J., Jonson G.J. // Br J Ophthalmol. – 2001 – Vol. 85. – P. 1277-82.
  27. Primary angle closure glaucoma. Oculometry, epidemiology, and genetics in a high risk population. / Alsbirk P.H. // Acta Ophthalmol. – 1976 – Vol. 54. – P. 531.
  28. Prevalence of glaucoma in Thailand: a population based survey in Rom Klao District, Bangkok. / Bourne R.A., Sukudom P., Foster P.J., Tantisevi V., Jitapunkul S., Lee P.S., et al. // Br J Ophthalmol. – 2003 – Vol. 87. – P. 1069-1074.
  29. The definition and classification of glaucoma in prevalence surveys. / Foster P.J., Buhrmann R., Quigley H.A., Johnson G.J. // Br J Ophthalmol. – 2002 – Vol. 86(2). – P. 238-42.
  30. The prevalence of primary angle closure glaucoma in European derived populations: a systematic review. / Day A.C., Baio G., Gazzard G., et al. // Br J Ophthalmol. – 2012 – 96(9). – P. 1162-7.
  31. Общая заболеваемость взрослого населения России в 2018 году: Статистические материалы. Часть IV. М., 2019 – С. 45-46. URL: https://www.rosminzdrav.ru/ministry/61/22/stranitsa-979/statisticheskie-informatsionnye-materialy/statisticheskiy-sbornik-2018-god.
  32. Comparison between Tendency-Oriented Perimetry (TOP) and octopus threshold perimetry / Morales J., Weitzman M.L., Gonzalez de la Rosa M. // Ophthalmology – 2000 - Vol.107, №1 – Р. 134-42.
  33. Combining structural and functional testing for detection of glaucoma / Shah N.N., Bowd C., Medeiros F.A., et al. // Ophthalmology – 2006 - Vol.113, №9 – Р. 1593-602.
  34. Levels of diagnostic studies. In Weinreb R.N., Greve E.L. (Eds.), Glaucoma diagnosis: Structure and Function. Consensus series I. / Coleman A., Friedman D., Gandolfi S., Singh K., Tuulonen A. // Amsterdam: Kugler Puplications – 2004 – Р. 9-12.
  35. Early detection of primary angle-closure glaucoma. Limbal and axial chamber depth screening in a high risk population (Greenland Eskimos). / Alsbirk P.H. // Acta Ophthalmol. – 1988 – Vol. 66. – P. 556-564.
  36. Followup of angle-closure glaucoma suspects. / Wilensky J.T., Kaufman P.L., Frohlichstein D., Gieser D.K., Kass M.A., Ritch R., et al. // Am J Ophthalmol. – 1993 – Vol. 115. – P. 338-346.
  37. Anatomical risk factors in primary angle-closure glaucoma. A ten-year follow- up survey based on limbal and axial anterior chamber depths in a high risk population. / Alsbirk P.H. Int Ophthalmol. – 1992 – Vol. 16. – P. 265-272.
  38. Five year risk of progression of primary angle closure suspects to primary angle closure: a population based study. / Thomas R., George R., Parikh R., et al. // Br J Ophthalmol. – 2003 – Vol. 87. – P. 450-454.
  39. The heritability and sibling risk of angle closure in Asians. / Amerasinghe N., Zhang J., Thalamuthu A., et al. // Ophthalmology. –  2011 – Vol. 118. – P. 480-5.
  40. Aetiology of the anatomical basis for primary angle-closure glaucoma. Biometrical comparisons between normal eyes and eyes with primary angle-closure glaucoma. / Lowe R.F. // Br J Ophthalmol. – 1970 – Vol. 54. – P. 161-169.
  41. Screening techniques for angleclosure glaucoma in rural Taiwan. / Congdon N.G., Quigley H.A., Hung P.T., Wang T.H., Ho T.C. // Acta Ophthalmol. – 1996 – Vol. 74. – P. 113-119.
  42. Rates of hospital admissions for primary angle closure glaucoma among Chinese, Malays, and Indians in Singapore. / Wong T.Y., Foster P.J., Seah S.K., Chew P.T. // Br J Ophthalmol. – 2000 – Vol. 84. – P. 990-992.
  43. Predisposing factors for chronic angle-closure glaucoma. / Salmon J.F. // Prog Retin Eye Res. – 1999 – Vol. 18. – P. 121-32.
  44. Acute angle-closure glaucoma. The second eye: an analysis of 200 cases./  Lowe R.F. Br J Ophthalmol. – 1962 – Vol. 46. – P. 641-50.
  45. Pharmacological and environmental factors in primary angle-closure glaucoma. Subak-Sharpe I., Low S., Nolan W., Foster P.J. // Br Med Bull. – 2010 – Vol. 93. – P. 125-43.
  46. Influence of family history as a risk factor on primary angle closure and primary open angle glaucoma in a Chinese population. / Kong X., Chen Y., Chen X., Sun X. // Ophthalmic Epidemiol. – 2011 – Vol. 18. – P. 226-32.
  47. Drug-induced acute angle closure glaucoma. / Lachkar Y., Bouassida W. // Curr. Opin. Ophthalmol. – 2007. – Vol. 18(2). – P. 129-33.
  48. Drug-induced ocular disorders. / Li J., Tripathi R.C., Tripathi B.J. // Drug Saf. – 2008 – Vol. 31. – P. 127-41.
  49. Age, gender, biometry, refractive error, and the anterior chamber angle among Alaskan Eskimos. / Wojciechowski R., Congdon N., Anninger W., Teo Broman A. // Ophthalmology. – 2003 – Vol. 110. – P. 365-75.
  50. Plateau iris in Asian subjects with primary angle closure glaucoma. / Kumar R.S., Tantisevi V., Wong M.H., et al. // Arch Ophthalmol. – 2009 – Vol. 127. – P. 1269-72.
  51. Estimation of width of angle of anterior chamber. Incidence and significance of the narrow angle. / Van Herick W., Shaffer R.N., Schwartz A. // Am J Ophthalmol. – 1969 – Vol. 68. – P. 626-9.
  52. Screening for narrow angles in the Singapore population: evaluation of new noncontact screening methods. / Lavanya R., Foster P.J., Sakata L.M., et al. // Ophthalmology. – 2008 – Vol. 115. – P. 1720-7.
  53. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial / Bengtsson B., Leske M.C., Hyman L., Heijl A. // Ophthalmology – 2007 - Vol.114, №2 – Р. 205-9.
  54. Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study / Caprioli J., Coleman A.L. // Ophthalmology – 2008 - Vol.115, №7 – Р. 1123-9.
  55. Diurnal IOP fluctuation: not an independent risk factor for glaucomatous visual field loss in high-risk ocular hypertension / Bengtsson B., Heijl A. // Graefes Arch. Clin. Exp. Ophthalmol – 2005 - Vol.243, №6 – Р. 513-8.
  56. Predictors of long-term progression in the early manifest glaucoma trial / Leske MC, Heijl A, Hyman L, et al. // Ophthalmology – 2007 - Vol.114, №11 – Р. 1965-72.
  57. The flashlight test and Van Herick’s test are poor predictors for occludable angles. / Thomas R., George T., Braganza A., Muliyil J. // Aust N Z J Ophthalmol. – 1996 – Vol. 24. – P. 251-256.
  58. Detection of gonioscopically occludable angles and primary angle-closure glaucoma by estimation of limbal chamber depth in Asians: Modified grading scheme. / Foster P.J., Devereux J., Alsbirk P.H., et al. // Br J Ophthalmol. – 2000 – Vol. 84. – P. 186-192.
  59. Anterior chamber depth measurement as a screening tool for primary angle-closure glaucoma in an East Asian population. / Devereux JG, Foster PJ, Baasanhu J, Uranchimeg D, Lee PS, Erdenbeleig T, Machin D, Johnson G.J., Alsbirk P.H. // Arch Ophthalmol. – 2000 – Vol. 118. – P. 257-263.
  60. The normal development of the human anterior chamber angle: a new system of descriptive grading / Spaeth G.L. // Trans. Ophthalmol. Soc. UK – 1971 – Vol. 91 – Р. 709-39.
  61. Gonioscopy anatomy of the angle of the anterior chamber of the eye. In. SRe, ed. In: Stereoscopic manual of gonioscopy / Shaffer R.N. // St. Louis, Mosby - 1962.
  62. In: Lehrbuch der klinischen Ophthalmologie / Kanski J.S., M. Glaukom. In: Kanski J. SMe, ed. // Stuttgart, New York Thieme - 1987.
  63. American Academy of Ophthalmology Glaucoma Panel. Preferred Practice Pattern® Guidelines. Primary Open-Angle Glaucoma. San Francisco, CA: American Academy of Ophthalmology, 2015. 111p.
  64. Optic nerve head and retinal nerve fiber layer analysis: a report by the American Academy of Ophthalmology / Lin S.C., Singh K., Jampel H.D. et al. // Ophthalmology – 2007 – Vol.114 – Р.1937-49.
  65. Normal visual field test results following glaucomatous visual field end points in the Ocular Hypertension Treatment Study / Keltner J.L., Johnson C.A., Levine R.A., et al. // Arch. Ophthalmol – 2005 – Vol. 123 – Р. 1201-6.
  66. Optic disc and visual field changes in a prospective longitudinal study of patients with glaucoma: comparison of scanning laser tomography with conventional perimetry and optic disc photography / Chauhan B.C., McCormick T.A., Nicolela M.T., LeBlanc R.P. // Arch Ophthalmol – 2001 – Vol. 119 – Р. 1492-9.  
  67. Results of the European Glaucoma Prevention Study / Miglior S., Zeyen T., Pfeiffer N., et al, European Glaucoma Prevention Study (EGPS) Group. // Ophthalmology – 2005 – Vol. 112 – Р. 366-75.
  68. Central corneal thickness of Caucasians, Chinese, Hispanics, Filipinos, African Americans, and Japanese in a glaucoma clinic. / Aghaian E., Choe J.E., Lin S., Stamper R.L. // Ophthalmology. – 2004 – Vol. 111. – P. 2211-9.
  69. Commingling analyses of central corneal thickness and adjusted intraocular pressure in an older Australian population / Rahman M.L., Bunce C., Healey P.R., et al. // Invest. Ophthalmol. Vis. Sci. – 2010 - Vol.51, №5 – Р. 2512-8.
  70. Corneal thickness measurement in the management of primary open-angle glaucoma: a report by the American Academy of Ophthalmology / Dueker D.K., Singh K., Lin S.C., et al. // Ophthalmology. – 2007 - №114 – Р. 1779-87.
  71. Corneal thickness as a risk factor for visual field loss in  patients with preperimetric glaucomatous optic neuropathy / Medeiros F.A., Sample P.A., Zangwill L.M., et al. // Am. J. Ophthalmol. – 2003 - №136 – Р. 805-13.
  72. Imaging of the optic nerve and retinal nerve fiber layer: an essential part of glaucoma diagnosis and monitoring / Kotowski J., Wollstein G., Ishikawa H., Schuman J.S. // Surv. Ophthalmol – 2014 – Vol. 59 – Р. 458-67.
  73. Diagnosing glaucoma progression with optical coherence tomography / Leung CK. // Curr. Opin. Ophthalmol – 2014 – Vol. 25 – Р. 104-11.
  74. Results of the European Glaucoma Prevention Study / Miglior S., Zeyen T., Pfeiffer N., et al, European Glaucoma Prevention Study (EGPS) Group. // Ophthalmology – 2005 – Vol. 112 – Р. 366-75.
  75. Baseline optical coherence tomography predicts the development of glaucomatous change in glaucoma suspects / Lalezary M., Medeiros F.A., Weinreb R.N., et al. // Am. J. Ophthalmol – 2006 – Vol. 142 – Р.576-82.
  76. Anterior chamber angle assessment techniques. / Friedman D.S., He M. // Surv Ophthalmol. – 2008 – Vol. 53. – P. 250-73.
  77. Anterior chamber depth in Mongolians. Variation with age, sex and method of measurement. / Foster P.J., Alsbirk P.H., Baahanhu J., et al. // Am J Ophthalmology. – 1997 – Vol. 124. P. 53-60.
  78. Evaluation of the anterior chamber angle in Asian Indian eyes by ultrasound biomicroscopy and gonioscopy. / Kaushik S., Jain R., Pandav S.S., Gupta A. // Indian J Ophthalmol. – 2006 – Vol. 54. – P. 159-63.
  79. Detection of primary angle closure using anterior segment optical coherence tomography in Asian eyes. / Nolan W.P., See J.L., Chew P.T., et al. // Ophthalmology. – 2007 – Vol. 114. – P. 33-9.
  80. High-definition optical coherence tomography imaging of the iridocorneal angle of the eye. / Wong H.T., Lim M.C., Sakata L.M., et al. // Arch Ophthalmol. 2009 – Vol. 127. – P. 256-60.
  81. Assessment of circumferential angle-closure by the iris-trabecular contact index with swept-source optical coherence tomography. / Baskaran M., Ho S.W., Tun T.A., et al. // Ophthalmology. – 2013 – Vol. 120. – P. 2226-31.
  82. Guidelines for Glaucoma Eye Care. International Council of Ophthalmology. San Francisco, California. 2015 – 20p.
  83. Pilocarpine induces an increase in the anterior chamber angular width in eyes with narrow angles. / Kobayashi H., Kobayashi K., Kiryu J., Kondo T. // Br J Ophthalmol. – 1999 – Vol. 83. – P. 553-558.
  84. World Glaucoma Association Consensus Statement:  Medical Treatment of Glaucoma The Netherlands: Kluger – 2010 – 310p.
  85. Pilocarpine induced acute angle closure. / Day A., Nolan W., Malik A., Viswanathan A., Foster P.  // BMJ Case Rep. – 2012 – Vol.8 – P. 56.
  86. Outcomes of different management options for malignant glaucoma: a retrospective study. / Debrouwere V., Stalmans P., Van Calster J. et al.  // Graefes. Arch. Clin. Exp. Ophthalmol.- 2012 – Vol. 250 (1). – P.  131-141.
  87. An Overview of Treatment Methods for Primary Angle Closure. / Anwar F., Turalba A. // Semin Ophthalmol. – 2017 – Vol. 32(1). – P. 82-85.
  88. Pharmacological therapy for glaucoma: a review. / Hoyng P.F., van Beek L.M. // Drugs. – 2000 – Vol. 59(3). – P. 411-34.
  89. Follow-up of primary angle closure suspects after laser peripheral iridotomy using ultrasound biomicroscopy and A-scan biometry for a period of 2 years. / Ramani K.K., Mani B., George R.J., Lingam V. // J Glaucoma. – 2009. – Vol. 18. – P. 521-7.
  90. Ocular symptoms and signs with preserved and preservative free glaucoma medications / Jaenen N., Baudouin C., Pouliquen P., et al. // Eur. J, Ophthalmol – 2007 - Vol.17, №3 – Р.341-9.
  91. Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based review / Olthoft C.M., Schuten J.S., Van de Borne B.W., Webers C.A. // Ophthalmology – 2005 - Vol.112, №6 – Р. 953-61.
  92. Compliance in patients prescribed eye drops for glaucoma / Patel S.C., Spaeth G.L. // Ophthalmic Surg – 1995 - Vol.26, №3 – Р. 953-61.
  93. The effect of Varying Dosing Interval on the Efficacy of Intraocular Pressure Lowering Drugs / Serle J.B., Toor A., Fahim M.M., et al. // Invest. Ophthalmol. Vis. Sci. – 2004 - Vol.45, №5 – Р. 97.
  94. Considerations in glaucoma therapy: fixed combinations versus their component medications /Higginbotham E.J.  // Clin. Ophthalmol – 2010 - №4 – Р. 1-9.
  95. Efficacy of antiglaucoma fixed combination therapy versus unfixed components in reducing intraocular pressure: a systematic review /Cox J.A., Mollan S.P., Bankart J., Robinson R.  // Br. J. Ophthalmol – 2008 - Vol.92, №6 – Р. 729-34.
  96. Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication / Pisella P.J., Pouliquen P., Baudouin C. // Br. J. Ophthalmol – 2002 - Vol.86, №4 – Р. 418-23.
  97. Glaucoma management in pregnancy: a questionnaire survey / Vaideanu D., Fraser S. // Eye (Lond) – 2007 - №21 – Р. 341-343.
  98. Timolol concentrations in breast milk of a woman treated for glaucoma: calculation of neonatal exposure / Madadi P., Koren G., Freeman D.J., et al. // J. Glaucoma – 2008 -№17 – Р. 329-331.
  99. Antiglaucoma medications during pregnancy and the risk of low birth weight: a population-based study / Ho J.D., Hu C.C., Lin H.C. // Br. J. Ophthalmol – 2009 - №10 – Р. 1283-1286.
  100. Acute angle closure glaucoma: acetazolamide therapy. / Lowe R.F . // Austral J Ophthalmol. – 1973 –  Vol. 1 – P. 24.
  101. Acute angle closure glaucoma: an evaluation of a protocol for acute treatment. / Choong Y.F., Irfan S., Menage M.J. // Eye (Lond). – 1999 – Vol.13 (Pt 5). – P. 613-6.
  102. Efficacy of medical therapy in the initial management of acute primary angle closure in Asians. / Ramli N., Chai S.M., Tan G.S., Husain R., Hoh S.T., Ho C.L., Aung T. // Eye (Lond). . – 2010 – Vol. 24(10). – P. 1599-602.
  103. Acute primary angle closure-treatment strategies, evidences and economical considerations. / Chan P.P., Pang J.C., Tham C.C. // Eye (Lond). – 2019 – Vol. 33(1). – P. 110-119.
  104. Corneal indentation to relieve acute angle-closure glaucoma. / Anderson D.R. // Am J Ophthalmol. – 1979 – Vol. 88. – P. 1091-3.
  105. Malignant glaucoma and its management. / Ruben S., Tsai J., Hitchings R. // Brit. J. Ophthamol – 1997 – Vol. 81. – P. 163-167.
  106. Treatment course of recurrent malignant glaucoma monitoring by ultrasound biomicroscopy: a report of two cases. / Shen C.J., Chen Y.Y., Sheu S.J. // Kaohsiung J Med Sci. – 2008 – Vol. 24(11). – P. 608-13.
  107. Clinical evidence for neuroprotection in glaucoma / Cordeiro M.F., Levin L.A. // Am. J. Ophthalmol – 2011 - Vol.152, №5 – Р. 715-6.
  108. Neuroprotection for treatment of glaucoma in adults / Sena D.F., Lindsley K. // Cochrane Database Syst Rev – 2013 - № 2: CD006539.
  109. A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment Study / Krupin T., Liebmann J.M., Greenfield D.S., et al. // Am. J. Ophthalmol. – 2011 - Vol.151, №4 – Р. 671-81.
  110. Laser Peripheral Iridotomy in Primary Angle Closure: A Report by the American Academy of Ophthalmology. / Radhakrishnan S., Chen P.P., Junk A.K., Nouri-Mahdavi K., Chen T.C.. // Ophthalmology. – 2018. – Vol. 125(7). – P. 1110-1120. 
  111. Laser peripheral iridotomy for the prevention of angle closure: a single-centre, randomised controlled trial. / He M., Jiang Y., Huang S., et al. // Lancet. – 2019 – Vol. 393. – P. 1609-18.
  112. Design and methodology of a randomized controlled trial of laser iridotomy for the prevention of angle closure in southern China: the Zhongshan Angle Closure Prevention trial. / Jiang Y., Friedman D.S., He M., et al.  // Ophthalmic Epidemiol. – 2010 – Vol. 17. – P. 321–32. 
  113. Functional evaluation of an ridotomy in primary angle closure eyes. / Sihota R., Rishi K., Srinivasan G., Gupta V., Dada T., Singh K. // Graefes Arch Clin Exp Ophthalmol. – 2016 –  Vol. 254(6). – P. 1141-9.
  114. Comparison of ultrasound biomicroscopic parameters after laser iridotomy in eyes with primary angle closure and primary angle closure glaucoma. / Dada T., Mohan S., Sihota R., et al. // Eye (Lond). – 2007 – Vol. 21. – P. 956-61.
  115. Long-term progression after laser peripheral iridotomy in Caucasian primary angle closure suspects. / Pearce F.C., Thomas R., Wong N.J., Walland M.J. // Clin Exp Ophthalmol. – 2018 – Vol. 46(7). – P. 828-830.
  116. Randomised controlled trial of screening and prophylactic treatment to prevent primary angle closure glaucoma. / Yip J.L., Foster P.J., Uranchimeg D., et al. // Br J Ophthalmol. – 2010 – Vol. 94. – P. 1472-7.
  117. Comparing brimonidine 0.2% to apraclonidine 1.0% in the prevention of intraocular pressure elevation and their pupillary effects following laser peripheral iridotomy. / Yuen N.S., Cheung P., Hui S.P. // Jpn J Ophthalmol. – 2005 – Vol. 49(2). – P. 89-92.
  118. Apraclonidine 0.5% versus brimonidine 0.2% for the control of intraocular pressure elevation following anterior segment laser procedures. / Chevrier R.L., Assalian A., Duperré J., Lesk M.R. // Ophthalmic Surg Lasers. – 1999 – Vol. 30(3). – P. 199-204.
  119. Lasers IN PRIMARY ANGLE CLOSURE. / W. K. Chee, S. Srinivasan, J. Cheng. // US Ophthalmic Review. – 2015 – Vol. 8(2). – P. 99–102.
  120. Immediate changes in intraocular pressure after laser peripheral iridotomy in primary angle-closure suspects. / Jiang Y., Chang D.S., Foster P.J., He M., Huang S., Aung T., Friedman D.S. // Ophthalmology. – 2012 – Vol. 119(2). – P. 283-8.
  121. Brimonidine 0.15% versus apraclonidine 0.5% for prevention of intraocular pressure elevation after anterior segment laser surgery / Chen T.C. // J. Cataract. Refract. Surg. – 2005 – Vol. 31. – Р. 1707-12.
  122. YAG laser iridotomy treatment for primary angle-closure in East Asian eyes. / Nolan W.P., Foster P.J., Devereux J.G., et al. // Br J Ophthalmol. – 2000 – Vol. 84. – P. 1255-1259.
  123. Laser iridotomy in dark irides. / de Silva D.J., Gazzard G., Foster P.. Br J Ophthalmol. – 2007 – Vol. 91(2). – P. 222-5.
  124. Argon laser peripheral iridoplasty and laser iridoectomy for plateau iris glaucoma. / Peng D., Zhang X., Yu K. // Zhonghua Yan Ke Za Zhi. – 1997 – Vol. 33. – P. 165-168.
  125. Laser surgery for angle closure glaucoma. / Liebmann J.M., Ritch R. // Semin Ophthalmol. – 2002 – Vol. 17(2). – P. 84-91.
  126. Efficacy of selective laser trabeculoplasty in primary angle-closure glaucoma: a randomized clinical trial. / Narayanaswamy A., Leung C.K., Istiantoro D.V., Perera S.A., Ho C.L., Nongpiur M.E., Baskaran M., Htoon H.M., Wong T.T., Goh D., Su D.H., Belkin M., Aung T. // JAMA Ophthalmol.  – 2015 – Vol. 133(2). – P. 206-12.
  127. Selective Laser Trabeculoplasty in Primary Angle-closure Glaucoma After Laser Peripheral Iridotomy: A Case-Control Study. / Ali Aljasim L., Owaidhah O., Edward D.P. // J Glaucoma. – 2016 –  Vol. 25(3). – P. 253-8.
  128. Control of intraocular pressure elevations after argon laser trabeculoplasty: comparison of brimonidine 0.2% to apraclonidine 1.0% / Barnes S.D., Campagna J.A., Dirks M.S., Doe E.A. // Ophthalmology – 1999 - №106 – Р. 2033-7.
  129. Cyclodestructive Procedures in Glaucoma: A Review of Current and Emerging Options / Dastiridou A., Katsanos A., Denis P., Francis B., Mikropoulos D., Teus M, Konstas A.// Adv. Ther. – 2018 - Vol.35, №12 – Р. 2103-2127.
  130. A two centre study of the dose-response relation for transscleral diode laser cyclophotocoagulation in refractory glaucoma / Murphy C.C., Burnett C.A., Spry P.G., et al. // Br. J. Ophthalmol – 2003 - Vol.87, №10 – Р. 1252-7.
  131. Cyclodestructive procedures for refractory glaucoma / Chen M.F., Kim C.H., Coleman A.L. // Cochrane Database Syst Rev. – 2019 - №10 - 3:CD012223.
  132. Cyclophotocoagulation in Glaucoma Management. / Stanley J. Berke // Endolaser Techniques in Opthalmology. – 2006 –  Vol. 4(2). – P. 74-81.
  133. Micropulse transscleral diode laser cyclophotocoagulation in the treatment of refractory glaucoma. / Tan A.M., Chockalingam M., Aquino M.C., Lim Z.I., See J.L., Chew P.T. // Clin Exp Ophthalmol. – 2010 – Vol. 38(3). – P. 266-72.
  134. Long-term evaluation of trabeculectomy in primary open angle glaucoma and chronic primary angle closure glaucoma in an Asian population. / Sihota R., Gupta V., Agarwal H.C. // Clin Exp Ophthalmol. – 2004 – Vol. 32. – P. 23-28.
  135. Trabeculectomy in patients with primary angle-closure glaucoma. / Chen Y.H., Lu D.W., Cheng J.H., et al. // J Glaucoma. – 2009 – Vol. 18. – P. 679-83.
  136. Trabeculectomy for acute primary angle closure. / Aung T., Tow S.L., Yap E.Y., et al. // Ophthalmology. – 2000 – Vol. 107. – P. 1298-302.
  137. The Moorfields safer surgery system. Middle East Afr. / Dhingra S., Khaw P.T. // J. Ophthalmol – 2009 – Vol. 16 – Р. 112-5.
  138. Long-term outcomes of needle revision of failing deep sclerectomy blebs / Koukkoulli A., Musa F., Anand N. // Graefes Arch. Clin. Exp. Ophthalmol – 2015 - Vol.253, №1 – Р.99-106. 
  139. Needling revision of trabeculectomies bleb morphology and long-term survival / Rotchford A.P., King A.J. // Ophthalmology – 2008 – Vol. 115 – Р. 1148-53.
  140. 5-Fluorouracil in initial trabeculectomy. A prospective, randomized, multicenter study / Goldenfeld M, Krupin T, Ruderman J.M., et al. // Ophthalmology – 1994 – Vol. 101 – Р.1024-9.
  141. Single intraoperative application of 5-Fluorouracil versus placebo in low-risk trabeculectomy surgery: a randomized trial / Leyland M., Bloom P., Zinicola E., et al. // J. Glaucoma – 2001 – Vol. 10 – Р. 452-7.
  142. Randomized trial of early phacoemulsification versus peripheral iridotomy to prevent intraocular pressure rise after acute primary angle closure. / Lam D.S., Leung D.Y., Tham C.C., et al. // Ophthalmology. – 2008 – Vol. 115. – P. 1134-40.
  143. Clinical outcomes after lens extraction for visually significant cataract in eyes with primary angle closure. / Shams P.N., Foster P.J. // J Glaucoma. – 2012. – Vol. 21. – P. 545-50.
  144. Initial management of acute primary angle closure: a randomized trial comparing phacoemulsification with laser peripheral iridotomy. / Husain R., Gazzard G., Aung T., et al. // Ophthalmology. – 2012 – Vol. 119. – P. 2274-81.
  145. Effectiveness in Angle-closure Glaucoma of Lens Extraction (EAGLE) Study Group. The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle-closure glaucoma (EAGLE): study protocol for a randomized controlled trial. / Azuara-Blanco A., Burr J.M., Cochran C., et al // Trial. – 2011 – Vol. 12 P. 133.
  146. Phacoemulsification and intraocular lens implantation in nanophthalmic eyes. Report of a medium-size series. / Faucher A., Hasanee K., Rootman D.S. // J Cataract Refract Surg. – 2002 –  Vol. 28. – P. 837-842.
  147. Primary phacoemulsification for uncontrolled angle-closure glaucoma. / Roberts T.V., Francis I.C., Lertusumitkul S., et al. // J Cataract Refract Surg. – 2000 – Vol. 26. – P. 1012-1016.
  148. Changes in anterior chamber angle width and depth after intraocular lens implantation in eyes with glaucoma. / Hayashi K., Hayashi H., Nakao F., Hayashi F. // Ophthalmology. – 2000 – Vol. 107. – P. 698-703.
  149. Phacotrabeculectomy in treatment of primary angleclosure glaucoma and primary open-angle glaucoma. / Lai J.S., Tham C.C., Chan J.C., Lam D.S. // Jpn J Ophthalmol. – 2004 – Vol. 48. – P. 408-411.
  150. Combined phacoemulsification, intraocular lens implantation and trabeculectomy in Asian patients with chronic angle closure glaucoma. / Tow S.L.C, Aung T., Oen F.T.S., Seah S.K.L. // Int Ophthalmol. – 2001 – Vol. 24. – P. 283-289.
  151. Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts. / Tham C.C., Kwong Y.Y., Leung D.Y., et al. // Ophthalmology. – 2009 – Vol. 116. – P. 725-31.
  152. Cataract surgery and its effect on intraocular pressure. / Obstbaum S.A. // J Cataract Refract Surg. – 1999 – Vol. 25. – P. 877.
  153. Lens extraction for uncontrolled glaucoma. / Gunning F.P., Greve E.L. // J Cataract Refract Surg. – 1998 – Vol. 24. – P. 1347-1356.
  154. Phacoemulsification Versus Phacotrabeculectomy in Primary Angle-closure Glaucoma With Cataract: Long-Term Clinical Outcomes. / Hansapinyo L., Choy B.N.K., Lai J.S.M., Tham C.C. // J Glaucoma. – 2020 – Vol. 29(1). – P. 15-23.
  155. Vitrectomy-phacoemulsification-vitrectomy for the management of aqueous misdirection syndromes in phakic eyes. / Sharma A., Sii F., Shah P., Kirkby G.R. // Ophthalmology. –  2006 – Vol. 113. – P. 1968-1973.
  156. Malignant glaucoma (aqueous misdirection) after pars plana vitrectomy. / Francis B.A., Babel D. // Ophthalmology. – 2000 – Vol. 107. – P. 1220-1222.
  157. Glaucoma surgery: Treatment and Techniques / Eds. Carreti L., Burrato L. Milan: Springer; 2018: 132
  158. Surgical outcomes of combined phacoemulsification and glaucoma drainage implant surgery for Asian patients with refractory glaucoma and cataract./  Chung A.N., Aung T., Wang J.C., Chew P.T.K. // Am J Ophthalmol. – 2004 – Vol. 137. – P. 294-300.
  159. Present and New Treatment Strategies in the Management of Glaucoma./ Kolko M. Open Ophthalmol J. 2015; 9: 89-100.
  160. Protection of retinal ganglion cells in glaucoma: Current status and future./ Shen J., Wang Y., Yao K. Exp Eye Res. 2021; 205: 108506.
  161. Исследование лиганд-рецепторного взаимодействия и биораспределения при различных режимах введения лекарственного средства, содержащего полипептиды сетчатки глаз скота./ Верлов Н.А., Доротенко А.Р.,Гулина А.С и др. Вестник офтальмологии. 2021; 137(5): 88-95.
  162. Excitotoxic neurodegeneration induced by deprivation of oxygen and glucose in isolated retina./ Romano C., Price M.T., Almli T., Olney J.W. Invest Ophthalmol Vis Sci. 1998; 39(2): 416-423.
  163. Мета-анализ рандомизированных клинических исследований эффективности и безопасности нейропротекторной терапии глаукомы с использованием комплекса водорастворимых полипептидных фракций./ Еричев В.П., Петров С.Ю., Волжанин А.В. Национальный журнал Глаукома. 2016; 15(4): 71-81.
  164. Ретинопротекция как терапевтическая стратегия глаукомы: обзор исторических и современных мировых тенденций./ Лоскутов И.А., Саверская Е.Н., Лоскутова Е.И. Национальный журнал Глаукома. 2017; 16(4): 86-97.
  165. Еричев В.П., Петров С.Ю., Волжанин А.В. Мета-анализ рандомизированных клинических исследований эффективности и безопасности нейропротекторной терапии глаукомы с использованием комплекса водорастворимых полипептидных фракций.  Национальный журнал Глаукома. 2016; 15(4): 71-81
  166. Егоров Е.А., Гветадзе А.А.,  Давыдова Н.Г. Антиоксидантный препарат в нейропротективной терапии при глаукоме // Вестник офтальмологии, № 2, 2013, стр. 67-69
  167. Мовсисян А.Б., Оганезова Ж.Г., Егоров Е.А. Возможности и результаты применения антиоксидантной терапии в офтальмологической практике. Вестник офтальмологии. 2022;138(5):122–128. https://doi.org/10.17116/oftalma2022138051122.
  168. Effect of technique on intraocular pressure after combined cataract and glaucoma surgery: an evidence-based review / Jampel H.D., Friedman D.S., Lubomski L.H., et al. // Ophthalmology – 2002 - №109 – Р. 2215-24.
  169. Factors predicting the success of trabeculectomy bleb enhancement with needling / Than J.Y.L., Al-Mugheiry T.S., Gale J., Martin K.R. // Br. J. Ophthalmol – 2018 - Vol.102, №12 – Р. 1667-1671.
  170. Ocular digital massage for the management of post-trabeculectomy underfiltering blebs / Ali M, Akhtar F. // J. Coll. Physicians Surg. Pak – 2011 - Vol.21, №11 – Р. 676-9.
  171. Economic considerations of the diagnosis and management for glaucoma in the developed world / Tuulonen A. // Curr. Opin. Ophthalmol – 2011 - Vol.22, №2 – Р. 102-9.
  172. Screening for Glaucoma: Comparative Effectiveness / Ervin A.M., Boland M.V., Myrowitz E.H., et al.  // Rockville (MD) - 2012. 12-EHC037-EF.
  173. Tunnel vision: the economic impact of primary open angle glaucoma – a dynamic economic model. / Taylor H.R., Crowston J., Keeffe J., et al. // Melbourne: Centre for Eye Research Australia, 2008. www.cera.org.au.
  174. Acute primary angle closure in an Asian population: long-term outcome of the fellow eye after prophylactic laser peripheral iridotomy. / Ang L.P., Aung T., Chew P.T.  // Ophthalmology. – 2000 – Vol. 107. – P. 2092-6.
  175. Behaviour of the fellow eye in acute angle-closure glaucoma. / Edwards R.S. // Br J Ophthalmol. – 1982 – Vol. 66. – P. 576-9.
  176. Follow-up of angle-closure glaucoma suspects. / Wilensky J.T., Kaufman P.L., Frohlichstein D., et al. // Am J Ophthalmol. – 1993 – Vol. 115. – P. 338-46.
  177. Interventions for angle-closure glaucoma: an evidence-based update. / Saw S.M., Gazzard G., Friedman D.S. // Ophthalmology. – 2003 – Vol. 110. – P. 1869-78.
  178. Value of prophylactic peripheral iridectomy on the second eye in angle-closure glaucoma. / Snow J.T. // Trans Ophthalmol Soc U K. – 1977 – Vol. 97. – P.189-91.

Для продолжения работы требуется Регистрация
На предыдущую страницу

Предыдущая страница

Следующая страница

На следующую страницу
Список литературы
На предыдущую главу Предыдущая глава
оглавление
Следующая глава На следующую главу

Оглавление

Данный блок поддерживает скрол*